X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

American Journal of Translational Research

期刊標題檢索 AM J TRANSL RES 最新評論: This magazine has published many articles. If interested, please direc... (2024-03-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[American Journal of Translational Research]您好,您是該頁面的第 162318 位訪客。

期刊簡介
期刊名稱American Journal of Translational Research American Journal of Translational Research
LetPub Score
5.1
50 ratings
Rate

Reputation
3.7

Influence
5.4

Speed
8.9

期刊簡稱AM J TRANSL RES
ISSN1943-8141
h-index45
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.301.0270.901
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Clinical Biochemistry
Q241 / 113
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q279 / 167
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q298 / 207

自引率 (2023-2024)5.90%自引率趨勢
掲載範囲
Information not localized
官方網站http://www.ajtr.org/
在線稿件提交http://www.e-century.us/submission/app.php?j=ajtr
開放訪問Yes
出版商e-Century Publishing Corporation
主題領域ONCOLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數661每年文章數趨勢
黃金OA百分比0.07%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3135/189
ONCOLOGYSCIEQ4250/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1943-8141%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【American Journal of Translational Research】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science Translational MedicineH-index: 168

    CiteScore: 26.70
    Stem Cell Research & TherapyH-index: 56

    CiteScore: 13.20
    Wiley Interdisciplinary Reviews-Nanomedicine and NanobiotechnologyH-index: 0

    CiteScore: 17.60
    EXPERT REVIEWS IN MOLECULAR MEDICINEH-index: 73

    CiteScore: 7.40
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 108

    CiteScore: 11.50
    Frontiers of MedicineH-index: 28

    CiteScore: 18.30
    Journal of Diabetes ResearchH-index: 33

    CiteScore: 8.40
    Biomed Research InternationalH-index: 94

    CiteScore: 6.70
    JOURNAL OF INVESTIGATIVE MEDICINEH-index: 59

    CiteScore: 11.20
    Journal of Cardiovascular Translational ResearchH-index: 44

    CiteScore: 6.10
    學科內最受檢索的期刊 頁面查看次數
    Biomed Research International394248
    Science Translational Medicine170378
    Stem Cell Research & Therapy136112
    Frontiers of Medicine89019
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE78848
    Journal of Diabetes Research56358
    Journal of Cardiovascular Translational Research32072
    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology30711
    EXPERT REVIEWS IN MOLECULAR MEDICINE17153
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION15938
  •  

    American Journal of Translational Research American Journal of Translational Research
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/21)
  [American Journal of Translational Research] 的評論撰寫評論
作者: A-宁静致远


領域: 医学
審稿時間: 2.0 month(s)
結果: 直接被接受


撰寫評論

2024-03-30 15:02:33 評論於
This magazine has published many articles. If interested, please direct message for fast response
(1) 讚! | A-宁静致远

作者: 45度沉默


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-29 18:01:44 評論於
Please translate the following paragraph into English and Japanese, and title them respectively as ":" and ":"
(0) 讚! | 45度沉默

作者: Rocky2022


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-03-28 20:36:57 評論於
If you need assistance, you can send a private message
(0) 讚! | Rocky2022

作者: 极乐骏奇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-18 08:39:30 評論於
Please help me
(0) 讚! | 极乐骏奇

作者: 极乐骏奇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-25 11:42:04 評論於
Emphasis on research direction: Oncology; Tumor; Experience sharing in bioinformatics analysis: This journal is no longer a warning journal, time flies
(0) 讚! | 极乐骏奇

作者: 邻家奇玮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-27 18:26:26 評論於
Can we talk privately now?
(0) 讚! | 邻家奇玮

作者: 葵花德运


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 17:16:30 評論於
This unexpectedly doesn't have a DOI, feels unreliable
(0) 讚! | 葵花德运

作者: Archer Anna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 09:05:50 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 75.0
Research Focus: Tumor
Experience: It took quite a while, about 5 months. The downside is that the impact factor at acceptance was 3.9, but it dropped to 2.2 in less than a month. However, one must learn to be content. Being accepted is what matters. The article itself didn't require too much effort, as the reviewers and editor didn't have many difficult suggestions, mostly related to formatting issues
(0) 讚! | Archer Anna

作者: Ivan Adams


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-25 12:09:22 評論於
Hello, I would like to ask if this alert is still divided into special issue and regular issue? It seems like there are more special issue alerts. Can I still submit?
(0) 讚! | Ivan Adams

作者: 终幕语薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-18 18:00:01 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Emphasized research direction: oncology; sharing of oncology experiences: journals still require, ethics, polishing, there are many opinions for revision, fortunately accepted
(0) 讚! | 终幕语薇

作者: 韦陀飞虎


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-05 19:57:31 評論於
The manuscript has been withdrawn and a warning has been issued
(0) 讚! | 韦陀飞虎

作者: Archer Anna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-03 19:19:51 評論於
I'm a bit confused. I haven't received any emails about revisions
(0) 讚! | Archer Anna

作者: Archer Anna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-03 16:50:15 評論於
The data for the past 22 years has been disclosed, so please check it yourself and don't mislead others
(0) 讚! | Archer Anna

作者: Archer Anna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-03 13:28:36 評論於
Brother, yours is in real-time, it will be announced in half a year
(0) 讚! | Archer Anna

作者: 无妄雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-10 18:15:27 評論於
You are looking at the real-time impact factor, but I see the estimated factor is still around 3.7
(0) 讚! | 无妄雪柳

作者: 慈悲珺琦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-07 11:05:52 評論於
If 4.06→3.94→1.955, I have never seen such a provocative magazine
(0) 讚! | 慈悲珺琦

作者: 慈悲珺琦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-06 23:05:08 評論於
Editorial speed: 2.0 | Submission acceptance rate: 95.0 Focused research areas: Oncology; Experience sharing in bioinformatics analysis: It's better not to submit in 2023, with the impact factor of 4.06 in 2020, 3.94 in 2021, and 1.96 in 2022. I've never seen such a tricky journal. Oncology Letters and Oncology Reports are better
(0) 讚! | 慈悲珺琦

作者: 无妄雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-30 12:52:27 評論於
Not yet, but it will be updated soon
(0) 讚! | 无妄雪柳

作者: 北斗珉瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-27 17:42:10 評論於
How can I contact you?
(0) 讚! | 北斗珉瑶

作者: 是你的康复呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-24 16:20:17 評論於
Hello, is this high-risk, or is it in the risk journal?
(0) 讚! | 是你的康复呀

作者: 无妄雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-19 23:39:42 評論於
The school's newsletter will be available by the end of the month
(0) 讚! | 无妄雪柳

作者: 无妄雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-19 12:31:17 評論於
I just received it too, there was no reminder before, and I only found out later that this journal does not have a DOI, and it's basically all Chinese, which makes it too easy to tip off
(0) 讚! | 无妄雪柳

作者: 一只成荫呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-18 21:53:02 評論於
Where can I see the latest warning periodicals?
(0) 讚! | 一只成荫呀

作者: 北斗珉瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-18 20:56:37 評論於
Really? Is this a scam? Don't scare me
(0) 讚! | 北斗珉瑶

作者: 无妄雪柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-07 10:43:42 評論於
For those who are still submitting, I suggest withdrawing your submission. I have already seen the latest alert journal, which is a high-risk journal. It will be published at the end of the month, so be cautious about submitting
(0) 讚! | 无妄雪柳

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/21)

開始撰寫 [American Journal of Translational Research] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*